Impax Asset Management Group plc Acquires 221,604 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

Impax Asset Management Group plc lifted its position in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 41.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 758,521 shares of the company's stock after purchasing an additional 221,604 shares during the quarter. Impax Asset Management Group plc owned approximately 1.82% of SI-BONE worth $10,604,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Champlain Investment Partners LLC increased its holdings in SI-BONE by 104.8% in the 1st quarter. Champlain Investment Partners LLC now owns 2,453,147 shares of the company's stock valued at $40,158,000 after buying an additional 1,255,610 shares during the period. Harbor Capital Advisors Inc. lifted its stake in SI-BONE by 440.5% during the second quarter. Harbor Capital Advisors Inc. now owns 192,380 shares of the company's stock worth $2,487,000 after purchasing an additional 156,790 shares during the period. Silvercrest Asset Management Group LLC boosted its holdings in SI-BONE by 13.8% during the first quarter. Silvercrest Asset Management Group LLC now owns 1,060,937 shares of the company's stock valued at $17,368,000 after purchasing an additional 128,702 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of SI-BONE by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 2,463,501 shares of the company's stock valued at $40,328,000 after purchasing an additional 43,670 shares during the period. Finally, American Century Companies Inc. raised its holdings in shares of SI-BONE by 22.8% in the 2nd quarter. American Century Companies Inc. now owns 1,986,476 shares of the company's stock worth $25,685,000 after buying an additional 368,637 shares in the last quarter. 98.11% of the stock is currently owned by institutional investors.

SI-BONE Price Performance

Shares of SI-BONE stock traded up $0.48 during trading on Friday, reaching $12.92. The company's stock had a trading volume of 607,878 shares, compared to its average volume of 392,341. SI-BONE, Inc. has a one year low of $11.76 and a one year high of $21.70. The stock has a 50-day moving average price of $14.03 and a two-hundred day moving average price of $14.29. The company has a current ratio of 8.25, a quick ratio of 8.12 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $541.86 million, a P/E ratio of -14.04 and a beta of 1.22.

Insider Buying and Selling at SI-BONE

In other SI-BONE news, insider Anthony J. Recupero sold 3,305 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $13.58, for a total value of $44,881.90. Following the transaction, the insider now directly owns 233,412 shares in the company, valued at approximately $3,169,734.96. This trade represents a 1.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last 90 days, insiders sold 7,147 shares of company stock worth $102,194. 3.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

SIBN has been the topic of a number of analyst reports. Morgan Stanley lowered their price target on SI-BONE from $21.00 to $19.00 and set an "overweight" rating on the stock in a research report on Tuesday, August 6th. Needham & Company LLC reaffirmed a "buy" rating and issued a $19.00 target price on shares of SI-BONE in a report on Wednesday. Finally, Truist Financial lifted their price target on shares of SI-BONE from $16.00 to $18.00 and gave the company a "buy" rating in a report on Wednesday. Six investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $23.00.

SI-BONE Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.